Rofecoxib, a New Cyclooxygenase 2 Inhibitor, Shows Sustained Efficacy, Comparable With Other Nonsteroidal Anti-inflammatory Drugs: A 6-Week and a 1-Year Trial in Patients With Osteoarthritis | Saag,K. | Archives of Family Medicine(2000),9(10):1124 | http://dx.doi.org/10.1001/archfami.9.10.1124 | |